Mechanistic investigation of Pluronic® based nano-crystalline drug-polymer solid dispersions

Pharmaceutical Research

Volumn 24, Issue 8, 2007, Pages 1551-1560

  Qian, Feng ^a   Tao, Jing ^b   Desikan, Sridhar ^a   Hussain, Munir ^a   Smith, Ronald L ^a  

^a BRISTOL MYERS SQUIBB   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Crystallization; Nano crystal; Pluronic ; Solid dispersion; Spray drying

Indexed keywords

BMS 347070; CYCLOOXYGENASE 2 INHIBITOR; MACROGOL 8000; POLOXAMER; UNCLASSIFIED DRUG;

ARTICLE; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG SOLUBILITY; DRUG STABILITY; MICROSCOPY; NANOANALYSIS; PRIORITY JOURNAL; X RAY DIFFRACTION;

CALORIMETRY, DIFFERENTIAL SCANNING; CRYSTALLIZATION; CYCLOOXYGENASE 2 INHIBITORS; EXCIPIENTS; FURANS; KINETICS; MESYLATES; PARTICLE SIZE; POLOXAMER; POLYETHYLENE GLYCOLS; TRANSITION TEMPERATURE;

EID: 34250799124     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-007-9275-7     Document Type: Article

References (19)

1. O. Chambin and V. Jannin. Interest of multifunctional lipid excipients: case of Gelucire 44/14. Drug Dev. Ind. Pharm. 31:527-534 (2005).
2. J. Hu, K. P. Johnston, and R. O. Williams, III. Nanoparticle engineering processes for enhancing the dissolution rates of poorly water soluble drugs. Drug Dev. Ind. Pharm. 30:233-245 (2004).
3. C. Leuner and J. Dressman. Improving drug solubility for oral delivery using solid dispersions. Eur. J. Pharm. Biopharm. 50:47-60 (2000).
4. E. Merisko-Liversidge, G. G. Liversidge, and E. R. Cooper. Nanosizing: a formulation approach for poorly-water-soluble compounds. Eur. J. Pharm. Sci. 18:113-120 (2003).
5. A. T. Serajuddin. Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. J. Pharm. Sci. 88:1058-1066 (1999).
6. S. Sethia and E. Squillante. Solid dispersions: revival with greater possibilities and applications in oral drug delivery. Crit Rev. Ther. Drug Carrier Syst. 20:215-247 (2003).
7. N. Subramanian and S. K. Ghosal. Enhancement of gastrointestinal absorption of poorly water soluble drugs via lipid based systems. Indian J. Exp. Biol. 42:1056-1065 (2004).
8. A. Martin. Physical Pharmacy, Lippincott Williams & Wilkins, Baltimore, MD, 1993.
9. S. X. Yin, M. Franchini, J. Chen, A. Hsieh, S. Jen, T. Lee, M. Hussain, and R. Smith. Bioavailability enhancement of a COX-2 inhibitor, BMS-347070, from a nanocrystalline dispersion prepared by spray-drying. J. Pharm. Sci. 94:1598-1607 (2005).
10. L. E. Alexander and Klug HP. X-ray Diffraction Procedures-for Polycrystalline and Amorphousmaterials, Wiley, New York, 1974.
11. T. G. Fox. Influence of diluent and of copolymer composition on the glass transition temperature of a polymer system. Bull. Am. Phys. Soc. 1:123 (1956).
12. A. Kabanov, J. Zhu, and V. Alakhov. Pluronic block copolymers for gene delivery. Adv. Genet. 53:231-261 (2005).
13. A. V. Kabanov and V. Y. Alakhov. Pluronic block copolymers in drug delivery: from micellar nanocontainers to biological response modifiers. Crit Rev. Ther. Drug Carrier Syst. 19:1-72 (2002).
14. G. S. Kwon. Polymeric micelles for delivery of poorly water-soluble compounds. Crit Rev. Ther. Drug Carrier Syst. 20:357-403 (2003).
15. C.S. Yang, D.D. Awschalom, and G.D. Stucky. Growth of CdS nanorods in nonionic amphiphilic triblock copolymer systems. Chem Mater. 14:1277-1284 (2002).
16. J. W. Mullin. Crystallization, Butterworth-Heinemann, Oxford, 2001.
17. D. W. Oxtoby. Nucleation of first-order phase transitions. Acc. Chem. Res. 31:91-97 (1998).
18. M. Volmer. Kinetik der Phasenbildung, Leipsig, Steinkopff, 1939.
19. M. C. Weinberg. A few topics concerning nucleation and crystallization in glasses. J. Non-Crystalline Solids 255:1-14 (1999).